Comments to FDA: Sunscreen Innovation Act Share page: Docket Number: FDA-2015-D-3990 Enclosed herein are comments on "Guidance for Industry; Sunscreen Innovation Act: Section 586C(c) Advisory Committee Process." Download Document Issues: OTC Medicines Sunscreen Related Posts Effectiveness of Phenylephrine as an Oral Decongestant Letter Comments on the Background Document on Propylparaben and Butylparaben in Skin-Applied Leave-On Products Jan 16, 2025 Comments Comments Regarding Enhancing Coverage of Preventative Services Under the Affordable Care Act Dec 26, 2024